Form 4: Myomo CEO Paul Gudonis Acquires 6,024 Shares Through Vesting of Performance-Based Restricted Stock Units
SEC Form 4 Filing
Myomo CEO Paul Gudonis acquired 6,024 shares of common stock through the vesting of performance-based restricted stock units.
Summary
- Paul Gudonis, CEO of Myomo, Inc., acquired 6,024 shares of common stock on June 9, 2024.
- The shares were acquired through the vesting of performance-based restricted stock units.
- These units were granted under the company's 2018 Stock Option and Incentive Plan.
- The vesting was based on Myomo's stock price performance relative to a peer group from June 10, 2021, to March 9, 2024.
- An additional 33,976 restricted stock units expired unvested.
Sentiment
Score: 6
Explanation: The document reflects a routine insider transaction. The vesting of shares is positive, but the expiration of unvested units is a minor negative. Overall, the sentiment is neutral to slightly positive.
Positives
- The vesting of performance-based restricted stock units suggests that the company met certain performance targets related to stock price.
- The CEO's acquisition of shares could be seen as a positive sign of confidence in the company's future performance.
Negatives
- The expiration of 33,976 restricted stock units indicates that the company did not meet all performance targets set for the vesting of these units.
Risks
- The performance-based vesting of stock units is tied to the company's stock price, which can be volatile and subject to market conditions.
- Failure to meet future performance targets could result in further unvested stock units.
Industry Context
This filing is a routine disclosure of insider transactions and is common for publicly traded companies. It provides transparency into executive compensation and ownership.
Comparison to Industry Standards
- Performance-based equity compensation is a common practice among publicly traded companies, particularly in the technology and healthcare sectors.
- The vesting criteria based on relative stock price performance against a peer group is a standard method to align executive interests with shareholder value.
- Companies like ReWalk Robotics and Ekso Bionics, which are in the same industry, also use similar equity compensation plans.
Stakeholder Impact
- The acquisition of shares by the CEO could be viewed positively by shareholders as it aligns management's interests with the company's performance.
- The expiration of unvested units may be a minor concern for some stakeholders.
Key Dates
| Date | Description |
|---|---|
| 06/10/2021 | Start date for measuring stock price performance for vesting of restricted stock units. |
| 03/09/2024 | End date for measuring stock price performance for vesting of restricted stock units. |
| 06/09/2024 | Date of the transaction where restricted stock units vested and shares were acquired. |
| 01/24/2025 | Date of signature on the SEC Form 4 filing. |
Keywords
Myomo, Paul Gudonis, stock acquisition, restricted stock units, vesting, performance-based, executive compensation, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.